Stocks Telegraph

Texas Instruments (TXN) Receives Equal-Weight Rating from Barclays Amid Mixed Sentiment

Texas Instruments Incorporated (TXN) has caught the attention of analysts once again as Tom O’Malley from Barclays initiated ...
Stocks Telegraph

Texas Instruments Incorporated (TXN) Receives Buy Rating from B of A Securities, Targeting Upside Potential

Texas Instruments Incorporated (TXN) has recently captured investor attention with a bullish rating upgrade from Vivek Arya ...
Stocks Telegraph

W. R. Berkley Corporation (WRB) Receives Market Perform Rating from BMO Capital, Signals Moderate Outlook

W. R. Berkley Corporation (WRB) recently garnered a “Market Perform” rating from BMO Capital’s analyst, Michael Zaremski, a ...
Stocks Telegraph

GitLab Inc. (GTLB) Receives Neutral Rating from BofA Securities Amid Market Volatility

GitLab Inc. (GTLB) has recently attracted attention from investors as it received a Neutral rating upgrade from Koji Ikeda of Bank of America Securities o. This shift comes amid a turbulent market ...
Stocks Telegraph

Penguin Solutions, Inc. (PENG) Undergoes Rating Change to Equal-Weight Amid Market Volatility

Barclays analyst Tom O’Malley assigned Penguin Solutions, Inc. (PENG) an Equal-Weight rating, with a price target set at $27.58. This shift comes as investors recalibrate expectations amidst ...
Stocks Telegraph

Biogen Inc. (BIIB) Receives Buy Rating from UBS Analysts, Target Raised to $225

Biogen Inc. (NASDAQ: BIIB) has recently been upgraded to a “Buy” rating by UBS analyst Michael Yee, with a new price target set at $225, signaling strong upside potential from the current trading ...
Stocks Telegraph

Xylem Inc. (XYL) Receives Neutral Rating from UBS, Price Target Suggests 10% Upside

In a recent note from Joshua Spector at UBS, Xylem Inc. (XYL) received a Neutral rating, indicating a stable outlook for the water technology and equipment company. This assessment comes with a price ...
Stocks Telegraph

Arrowhead Pharmaceuticals, Inc. (ARWR): Morgan Stanley Upgrades to Overweight with $100 Price Target

Arrowhead Pharmaceuticals, Inc. (ARWR) recently caught the attention of investors as Morgan Stanley’s analyst Michael Ulz upgraded the stock to an Overweight rating on April 21, 2026. This upgrade ...
Stocks Telegraph

Okta, Inc. (OKTA) Receives Overweight Rating: Analysts Project Significant Upside

Okta, Inc. (NASDAQ: OKTA) has recently garnered increased attention as Barclays analyst Saket Kalia upgraded the company to an “Overweight” rating on April 20, 2026, projecting a price target of $90.
Stocks Telegraph

The Williams Companies, Inc. (WMB): Goldman Sachs Downgrades to Buy with Target Price of $82

In a bold move reflecting optimism about future performance, Goldman Sachs analyst John Mackay upgraded The Williams ...
Stocks Telegraph

Exxon Mobil Corporation (XOM) Receives Neutral Rating from BNP Paribas, Price Target Potential of $165

Exxon Mobil Corporation (XOM) has recently been placed under a “Neutral” rating by Lucas Herrmann of BNP Paribas, as of April 17, 2026. With the stock currently trading at $146.44 and a price target ...
Stocks Telegraph

Vale S.A. (VALE): Barclays Assigns Equal-Weight Rating Amidst Modest Price Target

Vale S.A. (VALE) has recently captured investor attention with Barclays assigning an Equal-Weight rating to the stock o. The change in outlook reflects the current valuation of the stock at $17.82, ...